Skip to main navigation Skip to search Skip to main content

Open-label, Phase 1b/2 Study of Acalabrutinib Alone or in Combination with Rituximab in Subjects with Indolent B-cell Non-Hodgkin Lymphoma

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date02/18/20 → 08/17/24

Funding

  • Acerta Pharma: $25,400.00